Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 27% ± 10% | |
| astrocyte | 10 studies | 34% ± 17% | |
| glutamatergic neuron | 9 studies | 40% ± 27% | |
| oligodendrocyte | 9 studies | 30% ± 11% | |
| oligodendrocyte precursor cell | 9 studies | 30% ± 14% | |
| fibroblast | 8 studies | 24% ± 7% | |
| GABAergic neuron | 8 studies | 40% ± 23% | |
| macrophage | 7 studies | 25% ± 6% | |
| epithelial cell | 7 studies | 36% ± 13% | |
| adipocyte | 7 studies | 25% ± 6% | |
| interneuron | 6 studies | 41% ± 24% | |
| microglial cell | 6 studies | 25% ± 7% | |
| retina horizontal cell | 6 studies | 27% ± 9% | |
| retinal rod cell | 6 studies | 20% ± 3% | |
| ciliated cell | 6 studies | 23% ± 7% | |
| neuron | 5 studies | 31% ± 13% | |
| amacrine cell | 5 studies | 26% ± 9% | |
| goblet cell | 5 studies | 27% ± 18% | |
| pericyte | 5 studies | 21% ± 6% | |
| retinal cone cell | 4 studies | 32% ± 10% | |
| cardiac muscle cell | 4 studies | 23% ± 1% | |
| type I pneumocyte | 4 studies | 21% ± 6% | |
| type II pneumocyte | 4 studies | 20% ± 4% | |
| connective tissue cell | 4 studies | 18% ± 1% | |
| monocyte | 4 studies | 18% ± 1% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 3% | |
| GABAergic interneuron | 3 studies | 23% ± 3% | |
| granule cell | 3 studies | 20% ± 5% | |
| retinal ganglion cell | 3 studies | 40% ± 10% | |
| Mueller cell | 3 studies | 21% ± 5% | |
| glycinergic amacrine cell | 3 studies | 23% ± 4% | |
| rod bipolar cell | 3 studies | 24% ± 5% | |
| hepatocyte | 3 studies | 34% ± 17% | |
| dendritic cell | 3 studies | 20% ± 5% | |
| abnormal cell | 3 studies | 26% ± 8% | |
| club cell | 3 studies | 23% ± 6% | |
| lymphocyte | 3 studies | 20% ± 5% | |
| basal cell | 3 studies | 36% ± 14% | |
| transit amplifying cell | 3 studies | 33% ± 21% | |
| smooth muscle cell | 3 studies | 21% ± 1% | |
| mast cell | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2870.04 | 1445 / 1445 | 100% | 28.02 | 183 / 183 |
| lung | 100% | 3022.58 | 578 / 578 | 100% | 31.91 | 1155 / 1155 |
| ovary | 100% | 3483.25 | 180 / 180 | 100% | 27.69 | 430 / 430 |
| pancreas | 100% | 2101.21 | 328 / 328 | 100% | 29.84 | 178 / 178 |
| prostate | 100% | 3355.20 | 245 / 245 | 100% | 51.38 | 502 / 502 |
| brain | 100% | 4694.66 | 2641 / 2642 | 100% | 49.82 | 705 / 705 |
| breast | 100% | 3181.97 | 459 / 459 | 100% | 45.25 | 1116 / 1118 |
| intestine | 100% | 3152.42 | 966 / 966 | 100% | 33.81 | 525 / 527 |
| thymus | 100% | 3784.00 | 653 / 653 | 100% | 36.55 | 602 / 605 |
| uterus | 100% | 3325.47 | 170 / 170 | 99% | 26.20 | 456 / 459 |
| stomach | 100% | 2695.58 | 359 / 359 | 99% | 30.23 | 284 / 286 |
| kidney | 100% | 5008.99 | 89 / 89 | 99% | 39.37 | 894 / 901 |
| adrenal gland | 100% | 4444.66 | 258 / 258 | 99% | 42.84 | 228 / 230 |
| bladder | 100% | 3013.52 | 21 / 21 | 99% | 27.89 | 499 / 504 |
| skin | 100% | 3593.79 | 1808 / 1809 | 96% | 32.79 | 455 / 472 |
| liver | 100% | 1691.42 | 226 / 226 | 96% | 16.70 | 388 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.97 | 29 / 29 |
| spleen | 100% | 2172.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.74 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.57 | 1 / 1 |
| blood vessel | 100% | 3185.90 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2980.90 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2836.10 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 3474.67 | 831 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 21.67 | 76 / 80 |
| peripheral blood | 51% | 1275.83 | 471 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006289 | Biological process | nucleotide-excision repair |
| GO_0010821 | Biological process | regulation of mitochondrion organization |
| GO_0071577 | Biological process | zinc ion transmembrane transport |
| GO_0006882 | Biological process | intracellular zinc ion homeostasis |
| GO_0006829 | Biological process | zinc ion transport |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0031966 | Cellular component | mitochondrial membrane |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0005634 | Cellular component | nucleus |
| GO_0005385 | Molecular function | zinc ion transmembrane transporter activity |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0016922 | Molecular function | nuclear receptor binding |
| GO_0030374 | Molecular function | nuclear receptor coactivator activity |
| GO_0003682 | Molecular function | chromatin binding |
| Gene name | SLC30A9 |
| Protein name | Solute carrier family 30 member 9 Proton-coupled zinc antiporter SLC30A9, mitochondrial (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9) Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) |
| Synonyms | HUEL C4orf1 |
| Description | FUNCTION: Mitochondrial proton-coupled zinc ion antiporter mediating the export of zinc from the mitochondria and involved in zinc homeostasis, zinc mobilization as well as mitochondrial morphology and health . In nucleus, functions as a secondary coactivator for nuclear receptors by cooperating with p160 coactivators subtypes. Plays a role in transcriptional activation of Wnt-responsive genes (By similarity). . |
| Accessions | D6R9M6 ENST00000264451.12 A0A0S2Z512 A0A0S2Z514 ENST00000513699.5 Q6PML9 |